GDUFA self-identification is a mandatory FDA compliance process for generic Drug facilities and related sites. It supports FDA self-identification (Generic Drugs) by mandating structured annual submissions. The process ensures transparency, supports regulatory...

The National Drug Code or NDC system works as a structured method for identifying Drug products in the United States. It describes the format, assignment process, and regulatory requirements for companies that...

A US Agent is a mandatory requirement for foreign Medical Device manufacturers exporting to the United States under US agent FDA requirement guidelines. The agent serves as a regulatory communication link between...

Manufacturers outside the United Kingdom must appoint a UK Responsible Person (UKRP) to place Medical Devices on the Great Britain market. The UKRP acts as the manufacturer’s regulatory representative and primary contact...

An effective European Union (EU) regulatory strategy for Medical Devices involves a series of structured steps to ensure compliance with Regulation (EU) 2017/745. Manufacturers must address key requirements such as device classification,...

EU Marketing Authorization Holders oversee the entire lifecycle of medicinal products, ensuring they meet strict safety, effectiveness, and quality standards. They follow European Medicines Agency guidelines, maintain regulatory compliance, and submit timely...

Short Description FDA’s Electronic Common Technical Document (eCTD) is an important regulatory document that has a clear structural framework and submission requirements. Knowing the types of applications requiring eCTD, accepted eCTD versions,...

Short Description FDA-aligned best practices for achieving and maintaining FDA QSR compliance for Medical Device manufacturers are stringent but necessary. Knowing the key regulatory expectations across the device lifecycle and having practical...